2015
DOI: 10.3109/21678421.2015.1125502
|View full text |Cite
|
Sign up to set email alerts
|

Targeted assessment of lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis

Abstract: Estimating survival in amyotrophic lateral sclerosis (ALS) is challenging due to heterogeneity in clinical features of disease and a lack of suitable markers that predict survival. Our aim was to determine whether scoring of upper or lower motor neuron weakness is associated with survival. With this objective, 161 ALS subjects were recruited from two tertiary referral centres. Scoring of upper (UMN) and lower motor neuron (LMN) signs was performed, in addition to a brief questionnaire. Subjects were then follo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
40
2

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 39 publications
(43 citation statements)
references
References 35 publications
1
40
2
Order By: Relevance
“…Patients with ALS have differing rates of disease progression and while average survival is typically 2-3 years, a tail of long survivors occurs, partly due to disease pathology and also due to patient choices regarding respiratory support [88]. The severity of lower motor neuron involvement in ALS appears to be particularly relevant for survival [92], and therefore is an important measure to be evaluated in clinical trials.…”
Section: Als Clinical Trialsmentioning
confidence: 99%
“…Patients with ALS have differing rates of disease progression and while average survival is typically 2-3 years, a tail of long survivors occurs, partly due to disease pathology and also due to patient choices regarding respiratory support [88]. The severity of lower motor neuron involvement in ALS appears to be particularly relevant for survival [92], and therefore is an important measure to be evaluated in clinical trials.…”
Section: Als Clinical Trialsmentioning
confidence: 99%
“…Older age and bulbar involvement at disease onset (Chiò et al, 2009), cognitive impairment (Elamin et al, 2011), LMN dysfunction (Devine et al, 2016) and respiratory muscle weakness (Pinto et al) predict a shorter survival time. There are also some genes that modify the clinical course of ALS (Meyer et al, 2005, Fogh et al, 2016, Lopez-Lopez et al, 2014, Taylor et al, 2016.…”
Section: Factors That Modify Survival In Alsmentioning
confidence: 99%
“…The original authors of this grading system used it to demonstrate the focality of upper and lower motor neurone degeneration in ALS . It has subsequently been used to show that LMN burden is associated with survival in ALS (Devine et al, 2016).…”
Section: Clinical Correlates Of Hypermetabolism In Alsmentioning
confidence: 99%
See 2 more Smart Citations